Global Veterinary Vaccines Market 2017-2021 - Product Image

Global Veterinary Vaccines Market 2017-2021

  • ID: 4231762
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Advaxis
  • ARKO Labs
  • Ceva Animal Health
  • Epitopix
  • Merck
  • Nuovo Biologics
  • MORE
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.

The analysts forecast the global veterinary vaccines market to grow at a CAGR of 4.81% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global veterinary vaccines market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Veterinary Vaccines Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Elanco
- Merck
- Merial
- Zoetis

Other prominent vendors
- Advaxis
- AmpliPhi Biosciences
- Aratana Therapeutics
- ARKO Labs
- Bayer
- CanFel Therapeutics
- Ceva Animal Health
- Colorado Serum Company
- Epitopix
- Genus
- Hygieia Biological Laboratories
- ImmuCell
- Nexvet
- Nuovo Biologics
- UBI
- Valneva
- Vetoquinol
- Virbac

Market drivers
- Dependency on livestock products.
- For a full, detailed list, view the full report

Market challenges
- Manufacturing and storage issues.
- For a full, detailed list, view the full report

Market trends
- Robust R&D and improved product portfolio.
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Advaxis
  • ARKO Labs
  • Ceva Animal Health
  • Epitopix
  • Merck
  • Nuovo Biologics
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
PART 05: An overview of major animal diseases

PART 06: Market landscape
  • Market overview
  • Five forces analysis
PART 07: Market segmentation by technology
  • Live attenuated vaccines
  • Inactivated/Killed vaccines
  • Toxoid vaccines
  • DNA vaccines
  • Recombinant vector vaccines
PART 08: Geographical segmentation
  • Veterinary vaccines market in Americas
  • Veterinary vaccines market in EMEA
  • Veterinary vaccines market in APAC
PART 09: Decision framework

PART 10: Drivers and challenges
  • Market drivers
  • Market challenges
PART 11: Market trends

PART 12: Vendor landscape
  • Competitive scenario
PART 13: Key vendor analysis
  • Elanco
  • Merck
  • Merial
  • Zoetis
  • Other prominent vendors
PART 14: Appendix
  • List of abbreviations
List of Exhibits

Exhibit 01: Overview of major animal diseases
Exhibit 02: Global veterinary vaccines market snapshot
Exhibit 03: Global veterinary vaccines market 2016-2021 ($ millions)
Exhibit 04: Opportunity analysis in global veterinary vaccines market
Exhibit 05: Five forces analysis
Exhibit 06: Market segmentation by technology 2016
Exhibit 07: Veterinary live attenuated vaccines: Vendors and indications
Exhibit 08: Global veterinary live attenuated vaccines market 2016-2021 ($ millions)
Exhibit 09: Veterinary inactivated vaccines: Vendors and indications
Exhibit 10: Global veterinary inactivated vaccines market 2016-2021 ($ millions)
Exhibit 11: Examples: Veterinary toxoid vaccines with their indications and vendors
Exhibit 12: Global veterinary toxoid vaccines market 2016-2021 ($ millions)
Exhibit 13: Veterinary DNA vaccines
Exhibit 14: Global veterinary DNA vaccines market 2016-2021 ($ millions)
Exhibit 15: Veterinary recombinant vector vaccines
Exhibit 16: Global veterinary recombinant vector vaccines market 2016-2021 ($ millions)
Exhibit 17: Global veterinary vaccines market by geography 2016 and 2021
Exhibit 18: Global veterinary vaccines market revenue by geography 2016-2021 ($ millions)
Exhibit 19: Market scenario in Americas
Exhibit 20: Veterinary vaccines market in Americas 2016-2021 ($ millions)
Exhibit 21: Market scenario in EMEA
Exhibit 22: Veterinary vaccines market in EMEA 2016-2021 ($ millions)
Exhibit 23: Market scenario in APAC
Exhibit 24: Veterinary vaccines market in APAC 2016-2021 ($ millions)
Exhibit 25: Major requirements for CVB product approval
Exhibit 26: Impact of drivers and challenges
Exhibit 27: Key drivers and challenges for impact analysis
Exhibit 28: Recent strategic alliances in animal healthcare
Exhibit 29: Competitive structure analysis of global veterinary vaccines market 2016
Exhibit 30: Competitive factors of global veterinary vaccines market
Exhibit 31: Market penetration of lifestyle drug manufacturers worldwide 2016
Exhibit 32: Strategic success factors of companies in global veterinary vaccine market
Exhibit 33: Key news in veterinary vaccines market
Exhibit 34: Elanco: Key highlights
Exhibit 35: Elanco: Strength assessment
Exhibit 36: Elanco: Strategy assessment
Exhibit 37: Elanco: Opportunity assessment
Exhibit 38: Merck: Key highlights
Exhibit 39: Merck: Strength assessment
Exhibit 40: Merck: Strategy assessment
Exhibit 41: Merck: Opportunity assessment
Exhibit 42: Merial: Key highlights
Exhibit 43: Merial: Strength assessment
Exhibit 44: Merial: Strategy assessment
Exhibit 45: Merial: Opportunity assessment
Exhibit 46: Zoetis: Key highlights
Exhibit 47: Zoetis: Strength assessment
Exhibit 48: Zoetis: Strategy assessment
Exhibit 49: Allergan: Opportunity assessment
Exhibit 50: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Advaxis
  • ARKO Labs
  • Ceva Animal Health
  • Epitopix
  • Merck
  • Nuovo Biologics
  • MORE
New Report Released: - Global Veterinary Vaccines Market 2017-2021.

The author of the report recognizes the following companies as the key players in the global veterinary vaccines market: Elanco, Merck, Merial, and Zoetis.

Other Prominent Vendors in the market are: Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva Animal Health, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, ImmuCell, Nexvet, Nuovo Biologics, UBI, Valneva, Vetoquinol, and Virbac.

Commenting on the report, an analyst from the research team said: “One trend in market is inorganic growth strategies. The animal care market has been witnessing an increase in strategic alliances and acquisitions among vendors. The vendors undertake inorganic growth strategies such as acquisitions and/or partnerships to expand their product portfolio and to improve their penetration in the emerging markets.”

According to the report, one driver in market is advances in technology. The advances in technology have improved the overall pharmacokinetics and dynamics of vaccines. The use of cell line culture in the manufacture of viral vaccinations has increased, which have improved the quality of vaccinations. For instance, GE Healthcare and Valneva have collaborated to produce optimized cell culture for vaccine production. The advances in the purification process of vaccination have improved the product quality and reduced the cost. The development of new ligands for affinity chromatography, like lectin-affinity chromatography for downstream processing of cell culture, helped Sigma-Aldrich derive the influenza A viruses. These advances in technology are adding to the vaccine sales globally. For instance, the launch of various mobile applications such as PocketVet and Pet First Aid, help the owners get reminders regarding vaccines, which increases the awareness and boosts the usage of vaccines.

Further, the report states that one challenges in market is manufacturing and storage issues. Vaccines involve a complex network of processes, ranging from manufacturing to delivery. The cost-intensive manufacturing issues associated with vaccines get quadrupled with strict regulatory laws. The protocol set by the FAO for manufacturing animal vaccines involve stringent processes like Master Seed and Master Stock analysis. These processes are important in producing quality vaccines as they involve the analysis of microbes, which are used in vaccines manufacturing, followed by sterilization and storage processes. All these processes need to fulfill the required regulatory limits to get the desired product with safety and efficacy profiles. The downstream processing of these vaccines contributes to a major cost of production and is very crucial to conserve the purity of the product.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Elanco
  • Merck
  • Merial
  • Zoetis
  • Advaxis
  • AmpliPhi Biosciences
  • Aratana Therapeutics
  • ARKO Labs
  • Bayer
  • CanFel Therapeutics
  • Ceva Animal Health
  • Colorado Serum Company
  • Epitopix
  • Genus
  • Hygieia Biological Laboratories
  • ImmuCell
  • Nexvet
  • Nuovo Biologics
  • UBI
  • Valneva
  • Vetoquinol
  • Virbac
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll